Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Matrix metalloproteinases as valid clinical targets.

Barbara Fingleton1

  • 1Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. barbara.fingleton@vanderbilt.edu

Current Pharmaceutical Design
|February 23, 2007
PubMed
Summary

Matrix metalloproteinase inhibitors show promise for treating diseases beyond arthritis and cancer. Shorter, targeted treatment durations may reduce dose-limiting side effects, making MMP inhibition a viable therapeutic strategy.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of tumor proliferation by unlocking silent synapses on metastatic cancer cells.

bioRxiv : the preprint server for biology·2026
Same author

TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Scientific reports·2025
Same author

Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling.

Clinical & experimental metastasis·2025
Same author

Comparison of Lean, Obese, and Weight-Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T-cell Populations.

Cancer research·2025
Same author

Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model.

International journal of molecular sciences·2024
Same author

Trem2 deficiency attenuates breast cancer tumor growth in lean, but not obese or weight loss, mice and is associated with alterations of clonal T cell populations.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Biochemistry
  • Pharmacology
  • Enzymology

Background:

  • Matrix metalloproteinases (MMPs) are a family of enzymes targeted by pharmaceuticals for over two decades.
  • Despite extensive drug development, no MMP inhibitors have succeeded in clinical trials due to dose-limiting side effects.
  • MMP activity is implicated in the pathophysiology of various diseases, presenting potential therapeutic opportunities.

Purpose of the Study:

  • To explore alternative clinical settings where MMP inhibition is a potentially valid therapeutic strategy.
  • To review evidence from animal models supporting MMP inhibition.
  • To identify scenarios where reduced drug exposure may mitigate side effects.

Main Methods:

  • Review of existing literature on MMPs in disease pathophysiology.

Related Experiment Videos

Last Updated: Jul 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

  • Analysis of data from animal models investigating MMP inhibition.
  • Evaluation of potential therapeutic strategies focusing on reduced treatment duration and systemic exposure.

    • Main Results:

    • Strong evidence suggests MMP involvement in diseases beyond arthritis and cancer.
    • Animal models demonstrate the efficacy of MMP inhibition in specific disease contexts.
    • Targeted, short-term, or localized MMP inhibition may circumvent historical side-effect issues.

    Conclusions:

    • MMP inhibition remains a promising therapeutic avenue, particularly in diseases with strong MMP involvement.
    • Alternative administration strategies, such as reduced duration or systemic exposure, can overcome previous clinical trial limitations.
    • Further investigation into specific disease settings and optimized MMP inhibitor therapy is warranted.